These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17376044)

  • 1. Preventive effects of vitamin K on recurrent disease in patients with hepatocellular carcinoma arising from hepatitis C viral infection.
    Kakizaki S; Sohara N; Sato K; Suzuki H; Yanagisawa M; Nakajima H; Takagi H; Naganuma A; Otsuka T; Takahashi H; Hamada T; Mori M
    J Gastroenterol Hepatol; 2007 Apr; 22(4):518-22. PubMed ID: 17376044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot study.
    Mizuta T; Ozaki I; Eguchi Y; Yasutake T; Kawazoe S; Fujimoto K; Yamamoto K
    Cancer; 2006 Feb; 106(4):867-72. PubMed ID: 16400650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vitamin K2 on the recurrence in patients with hepatocellular carcinoma.
    Hotta N; Ayada M; Sato K; Ishikawa T; Okumura A; Matsumoto E; Ohashi T; Kakumu S
    Hepatogastroenterology; 2007; 54(79):2073-7. PubMed ID: 18251162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study.
    Kudo M; Sakaguchi Y; Chung H; Hatanaka K; Hagiwara S; Ishikawa E; Takahashi S; Kitai S; Inoue T; Minami Y; Ueshima K
    Oncology; 2007; 72 Suppl 1():132-8. PubMed ID: 18087194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vitamin K2 on the recurrence of hepatocellular carcinoma.
    Yoshida H; Shiratori Y; Kudo M; Shiina S; Mizuta T; Kojiro M; Yamamoto K; Koike Y; Saito K; Koyanagi N; Kawabe T; Kawazoe S; Kobashi H; Kasugai H; Osaki Y; Araki Y; Izumi N; Oka H; Tsuji K; Toyota J; Seki T; Osawa T; Masaki N; Ichinose M; Seike M; Ishikawa A; Ueno Y; Tagawa K; Kuromatsu R; Sakisaka S; Ikeda H; Kuroda H; Kokuryu H; Yamashita T; Sakaida I; Katamoto T; Kikuchi K; Nomoto M; Omata M
    Hepatology; 2011 Aug; 54(2):532-40. PubMed ID: 21574174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma.
    Yoshiji H; Noguchi R; Toyohara M; Ikenaka Y; Kitade M; Kaji K; Yamazaki M; Yamao J; Mitoro A; Sawai M; Yoshida M; Fujimoto M; Tsujimoto T; Kawaratani H; Uemura M; Fukui H
    J Hepatol; 2009 Aug; 51(2):315-21. PubMed ID: 19501932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
    Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
    Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment.
    Yamashiki N; Yoshida H; Tateishi R; Shiina S; Teratani T; Yoshida H; Kondo Y; Oki T; Kawabe T; Omata M
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2155-60. PubMed ID: 18031374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
    De Martin E; Senzolo M; Boninsegna S; Guido M; Masier A; Germani G; Tomat S; Brolese A; Neri D; Cillo U; Gambato M; Russo FP; Farinati F; Burra P
    Transplant Proc; 2008; 40(6):1974-5. PubMed ID: 18675104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
    Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
    J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis.
    Kawamura Y; Ikeda K; Arase Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Kumada H
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1739-46. PubMed ID: 18713301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytokine-induced killer cell fusion to lower recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization sequentially combined with radiofrequency ablation: a randomized trial].
    Zhao M; Wu PH; Zeng YX; Xia JC; Zhang FJ; Xian LJ; Zhang YP; Zhou K; Fan WJ; Zhang L; Gao F; Zhou QM
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1823-8. PubMed ID: 17054858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
    Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
    Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.
    Yin XY; Xie XY; Lu MD; Xu HX; Xu ZF; Kuang M; Liu GJ; Liang JY; Lau WY
    Cancer; 2009 May; 115(9):1914-23. PubMed ID: 19241423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of menatetrenone, a vitamin k2 analog, on recurrence of hepatocellular carcinoma after surgical resection: a prospective randomized controlled trial.
    Ishizuka M; Kubota K; Shimoda M; Kita J; Kato M; Park KH; Shiraki T
    Anticancer Res; 2012 Dec; 32(12):5415-20. PubMed ID: 23225445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin K2 on the development of hepatocellular carcinoma in type C cirrhosis.
    Kojima K; Tamano M; Akima T; Hashimoto T; Kuniyoshi T; Maeda C; Majima Y; Kusano K; Murohisa T; Iijima M; Hiraishi H
    Hepatogastroenterology; 2010; 57(102-103):1264-7. PubMed ID: 21410069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative radiofrequency ablation for hepatocellular carcinoma: long-term results in a large series.
    Kim YS; Rhim H; Lim HK; Choi D; Lee WJ; Jeon TY; Joh JW; Kim SJ
    Ann Surg Oncol; 2008 Jul; 15(7):1862-70. PubMed ID: 18463926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis.
    Ikeda K; Arase Y; Kobayashi M; Saitoh S; Someya T; Hosaka T; Suzuki Y; Suzuki F; Tsubota A; Akuta N; Kumada H
    J Gastroenterol; 2003; 38(9):865-76. PubMed ID: 14569444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.